Palazestrant in combination with ribociclib demonstrated encouraging activity across all dose cohorts and subgroups ; Median PFS was 15.5 months in the 120 mg palazestrant cohort ...
US Army Secretary Dan Driscoll said the military needed to "completely disrupt the system" that "lined the primes' pockets ...
5h
How American Resources' US$40 Million Equity Raise Could Shape AREC's Rare Earth Expansion Strategy
In October 2025, American Resources Corporation announced a series of private placements and a follow-on equity offering totaling about US$40 million to institutional investors, including the sale of ...
Unexpected performances and surprising results are a feature of college football. Where will they happen? Our experts offer ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced landmark results demonstrating ...
ENHERTU is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback